Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-22-007083
Filing Date
2022-10-26
Accepted
2022-10-26 15:39:07
Documents
1
Period of Report
2022-10-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2215
  Complete submission text file 0001683168-22-007083.txt   3823
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 1730 RUE SAINT-PATRICK UNIT 601 MONTREAL Z4 H3K0B2
Business Address
Chamoun Malek (Reporting) CIK: 0001951769 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41282 | Film No.: 221333176